Steno Diabetes Center Odense Revenue and Competitors
Estimated Revenue & Valuation
- Steno Diabetes Center Odense's estimated annual revenue is currently $32.4M per year.
- Steno Diabetes Center Odense's estimated revenue per employee is $270,000
Employee Data
- Steno Diabetes Center Odense has 120 Employees.
- Steno Diabetes Center Odense grew their employee count by 4% last year.
Steno Diabetes Center Odense's People
Name | Title | Email/Phone |
---|
Steno Diabetes Center Odense Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $54.4M | 183 | 6% | N/A | N/A |
#2 | $18M | 74 | -4% | N/A | N/A |
#3 | $162.7M | 482 | 39% | N/A | N/A |
#4 | $42.8M | 144 | 8% | N/A | N/A |
#5 | $26.5M | 98 | 4% | N/A | N/A |
#6 | $33.2M | 123 | -2% | N/A | N/A |
#7 | $29.7M | 110 | 12% | N/A | N/A |
#8 | $15.5M | 66 | -21% | $29.7M | N/A |
#9 | $1645.8M | 4354 | 13% | N/A | N/A |
#10 | $43.7M | 147 | 18% | N/A | N/A |
What Is Steno Diabetes Center Odense?
With the overall objective to call for stronger action against the debilitating disease of diabetes in Region of Southern Denmark, Steno Diabetes Center Odense (SDCO) was established on January 1, 2018, with a 10-year grant from the Novo Nordisk Foundation (NNF). SDCO is run and owned by Region of Southern Denmark with Jan Erik Henriksen as CEO. One of the primary tasks of SDCO is to be a center of excellence for the development of new approaches to treating and preventing diabetes with focus on the following 4 core activities: 1. Treatment and prevention of late complications 2. Clinical research 3. Competency development of health professionals 4. Cross-sectorial collaboration
keywords:N/AN/A
Total Funding
120
Number of Employees
$32.4M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $36.3M | 125 | 5% | N/A |
#2 | $13.5M | 135 | 0% | N/A |
#3 | $58.2M | 196 | 8% | N/A |
#4 | $31.6M | 198 | 5% | N/A |